Machine Learning and Pregnancy Success Prediction in Fertility Treatments
Launched by IRCCS SAN RAFFAELE · Mar 18, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how machine learning, a type of artificial intelligence, can help predict the chances of success for patients undergoing fertility treatments like in vitro fertilization (IVF). The goal is to analyze large amounts of data from previous IVF treatments to identify patterns that could lead to better pregnancy outcomes. By using this information, doctors may be able to personalize treatment plans for each patient, which could improve the chances of a successful pregnancy while also easing the emotional and financial stress often associated with fertility treatments.
To participate in this trial, women between the ages of 18 and 43 who have undergone assisted reproductive technology procedures, like IVF or ICSI, between 2019 and 2024 may be eligible. However, those with incomplete medical records or outside the specified age range will not be included. While the trial is not yet recruiting participants, it aims to gather valuable insights that could enhance future fertility treatments and support couples struggling with infertility.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who underwent ART procedures, including IVF and ICSI, between 2019 and 2024.
- • Women aged between 18 and 43 years.
- Exclusion Criteria:
- • Patiens with incomplete or missing data records that do not provide sufficient information for analysis.
- • women outside the 18 to 43 age range
About Irccs San Raffaele
IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported